NexImmune, Inc.
General ticker "NEXI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $70.5K (TTM average)
NexImmune, Inc. does not follow the US Stock Market performance with the rate: -9.8%.
Estimated limits based on current volatility of 17.5%: low 0.00$, high 0.00$
Factors to consider:
- Total employees count: 6 (-88.0%) as of 2023
- Top business risk factors: Insufficient funding, Delisting risk, Market competition, Operational and conduct risks, Regulatory and compliance
- Current price 100.0% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.77$, 3.25$]
- 2024-12-30 to 2025-12-30 estimated range: [0.54$, 2.18$]
Financial Metrics affecting the NEXI estimates:
- Positive: with PPE of -0.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -1310.35 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: 18.93 < Shareholder equity ratio, % of 40.84 <= 41.86
- Negative: Industry earnings per price (median), % of -22.08 <= 0
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
Short-term NEXI quotes
Long-term NEXI plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $53.26MM | $63.08MM | $32.97MM |
| Operating Income | $-53.26MM | $-63.08MM | $-32.97MM |
| Non-Operating Income | $2.35MM | $0.58MM | $0.63MM |
| Interest Expense | $0.91MM | $0.00MM | $0.00MM |
| R&D Expense | $37.46MM | $47.15MM | $19.28MM |
| Income(Loss) | $-50.90MM | $-62.51MM | $-32.34MM |
| Profit(Loss)* | $-51.75MM | $514.18MM | $-32.34MM |
| Stockholders Equity | $83.76MM | $32.30MM | $3.51MM |
| Assets | $91.03MM | $43.06MM | $8.59MM |
| Operating Cash Flow | $-45.79MM | $-51.19MM | $-31.43MM |
| Capital expenditure | $2.35MM | $1.26MM | $0.05MM |
| Investing Cash Flow | $-53.81MM | $50.32MM | $-0.04MM |
| Financing Cash Flow | $124.89MM | $5.18MM | $0.00MM |
| Earnings Per Share** | $-56.67 | $534.29 | $-30.82 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.